Cassava Sciences to Present at the Raymond James 2021 Human Health Innovation Conference
June 17 2021 - 4:01PM
Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage
biotechnology company focused on Alzheimer’s disease, today
announced that it has been invited to present at the Raymond James
2021 Human Health Innovation Conference, a virtual event taking
place on June 21-23, 2021.
Remi Barbier, President & CEO, and Eric
Schoen, Chief Financial Officer, will present a corporate overview
on Tuesday, June 22nd at 3:20pm Eastern time. Management will also
host meetings with institutional investors during this conference.
A webcast of management’s presentation will be available for replay
through September 20, 2021, on the Company’s website,
www.CassavaSciences.com, under the ‘Investors’ tab.
About Cassava Sciences,
Inc.Cassava Sciences’ mission is to discover and develop
innovations for chronic, neurodegenerative conditions. Over the
past 10 years, Cassava Sciences has combined state-of-the-art
technology with new insights in neurobiology to develop novel
solutions for Alzheimer’s disease. For more information, please
visit: https://www.CassavaSciences.com.
For More Information Contact:
Eric Schoen, Chief Financial
Officereschoen@CassavaSciences.com(512) 501-2450
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Apr 2023 to Apr 2024